Redox markers and inflammation are differentially affected by atorvastatin, pravastatin or simvastatin administered before endotoxin-induced acute lung injury

International Immunopharmacology

Volumn 17, Issue 1, 2013, Pages 57-64

  Melo, Adriana Correa ^a   Valença, Samuel Santos ^b   Gitirana, Lycia Brito ^b   Santos, Juliana Carvalho ^c   Ribeiro, Lima Marcelo ^c   Machado, Mariana Nascimento ^b   Magalhães, Clarissa Bichara ^b   Zin, Walter Araújo ^b   Porto, Luís Cristóvão ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c UNIVERSIDADE SÃO FRANCISCO   (Brazil)

Author keywords

Acute lung injury; Atorvastatin; Inflammation; Oxidative stress; Pravastatin; Simvastatin

Indexed keywords

ALANINE AMINOTRANSFERASE; ATORVASTATIN; BIOLOGICAL MARKER; CATALASE; INTERLEUKIN 6; MALONALDEHYDE; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOPEROXIDASE; PRAVASTATIN; SIMVASTATIN; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LUNG INJURY; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HISTOPATHOLOGY; LEUKOCYTE; LIPID PEROXIDATION; LUNG LAVAGE; MALE; MOUSE; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

EID: 84879195519     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2013.05.016     Document Type: Article

References (57)

1. Bellingan GJ. The pulmonary physician in critical care 6: the pathogenesis of ALI/ARDS. Thorax 2002;57:540-6. (Pubitemid 34627988)
2. Devaney J, Contreras M, Laffey JG. Clinical review: gene-based therapies for ALI/ARDS: where are we now? Crit Care 2011;15:224.
3. Bhatia M, He M, Zhang H, Moochhala S. Sepsis as a model of SIRS. Front Biosci 2009;14:4703-11.
4. Gutierrez HH, Nieves B, Chumley P, Rivera A, Freeman BA. Nitric oxide regulation of superoxide-dependent lung injury: oxidant-protective actions of endogenously produced and exogenously administered nitric oxide. Free Radic Biol Med 1996;21: 43-52. (Pubitemid 26230404)
5. Loenders B, Van Mechelen E, Nicolai S, Buyssens N, Van Osselaer N, Jorens PG, et al. Localization of extracellular superoxide dismutase in rat lung: neutrophils and macrophages as carriers of the enzyme. Free Radic Biol Med 1998;24: 1097-106. (Pubitemid 28246723)
6. Lai PS, Fresco JM, Pinilla MA, Macias AA, Brown RD, Englert JA, et al. Chronic endotoxin exposure produces airflow obstruction and lung dendritic cell expansion. Am J Respir Cell Mol Biol 2012;47:209-17.
7. Sharma R, Kaundal RK, Sharma SS. Amelioration of pulmonary dysfunction and neutrophilic inflammation by PPAR gamma agonist in LPS-exposed guinea pigs. Pulm Pharmacol Ther 2009;22:183-9.
8. Lagente V, Planquois JM, Leclerc O, Schmidlin F, Bertrand CP. Oxidative stress is an important component of airway inflammation in mice exposed to cigarette smoke or lipopolysaccharide. Clin Exp Pharmacol Physiol 2008;35:601-5. (Pubitemid 351490092)
9. Lima Trajano ET, Sternberg C, Caetano M, Santos Silva MA, Porto LC, Santos JC, et al. Endotoxin-induced acute lung injury is dependent upon oxidative response. Inhal Toxicol; 2011;23:918-26.
10. Minder CM, Blaha MJ, Horne A, Michos ED, Kaul S, Blumenthal RS. Evidence-based use of statins for primary prevention of cardiovascular disease. Am J Med; 2012;125:440-6.
11. Schonbeck U, Libby P. Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents? Circulation 2004;109:II18-26. (Pubitemid 38724152)
12. Shovman O, Levy Y, Gilburd B, Shoenfeld Y. Antiinflammatory and immunomodulatory properties of statins. Immunol Res 2002;25:271-85. (Pubitemid 34454717)
13. Mason RP. Molecular basis of differences among statins and a comparison with antioxidant vitamins. Am J Cardiol 2006;98:34P-41P.
14. Rosenson RS. Statins in atherosclerosis: lipid-lowering agents with antioxidant capabilities. Atherosclerosis 2004;173:1-12. (Pubitemid 38228462)
15. Jacobson JR. Statins in endothelial signaling and activation. Antioxid Redox Signal 2009;11:811-21.
16. Kumar A, Sharma N, Gupta A, Kalonia H, Mishra J. Neuroprotective potential of atorvastatin and simvastatin (HMG-CoA reductase inhibitors) against 6-hydroxydopamine (6-OHDA) induced Parkinson-like symptoms. Brain Res 2012;1471:13-22.
17. CostantineMM, Tamayo E, Lu F, Bytautiene E, Longo M,Hankins GD, et al. Using pravastatin to improve the vascular reactivity in a mousemodel of soluble fms-like tyrosine kinase-1-induced preeclampsia. Obstet Gynecol 2010;116:114-20.
18. Xavier AM, Serafim KG, Higashi DT, Vanat N, Flaiban KK, Siqueira CP, et al. Simvastatin improves morphological and functional recovery of sciatic nerve injury in Wistar rats. Injury 2012;43:284-9.
19. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
20. Nagato AC, Bezerra FS, Lanzetti M, Lopes AA, Silva MA, Porto LC, et al. Time course of inflammation, oxidative stress and tissue damage induced by hyperoxia in mouse lungs. Int J Exp Pathol; 2012;93:269-78.
21. Bannister JV, Bannister WH, Rotilio G. Aspects of the structure, function, and applications of superoxide dismutase. CRC Crit Rev Biochem 1987;22:111-80.
22. Aebi H. Catalase in vitro. Methods Enzymol 1984;105:121-6.
23. Draper HH, Squires EJ,Mahmoodi H,Wu J, Agarwal S, Hadley M. A comparative evaluation of thiobarbituric acid methods for the determination of malondialdehyde in biological materials. Free Radic Biol Med 1993;15:353-63. (Pubitemid 23283552)
24. Hermes-Lima M, Willmore WG, Storey KB. Quantification of lipid peroxidation in tissue extracts based on Fe(III)xylenol orange complex formation. Free Radic Biol Med 1995;19:271-80.
25. Lenz AG, Costabel U, Shaltiel S, Levine RL. Determination of carbonyl groups in oxidatively modified proteins by reduction with tritiated sodium borohydride. Anal Biochem 1989;177:419-25. (Pubitemid 19088284)
26. Suzuki K, Ota H, Sasagawa S, Sakatani T, Fujikura T. Assay method formyeloperoxidase in human polymorphonuclear leukocytes. Anal Biochem 1983;132:345-52. (Pubitemid 13048589)
27. Romitelli F, Santini SA, Chierici E, Pitocco D, Tavazzi B, Amorini AM, et al. Comparison of nitrite/nitrate concentration in human plasma and serum samples measured by the enzymatic batch Griess assay, ion-pairing HPLC and ion-trap GC-MS: the importance of a correct removal of proteins in the Griess assay. J Chromatogr B Analyt Technol Biomed Life Sci 2007;851:257-67. (Pubitemid 46720148)
28. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25:402-8. (Pubitemid 34164012)
29. Mortola JP, Noworaj A. Two-sidearm tracheal cannula for respiratory airflow measurements in small animals. J Appl Physiol 1983;55:250-3. (Pubitemid 13075349)
30. Bates JH, Rossi A, Milic-Emili J. Analysis of the behavior of the respiratory system with constant inspiratory flow. J Appl Physiol 1985;58:1840-8. (Pubitemid 15013843)
31. Bates JH, Ludwig MS, Sly PD, Brown K, Martin JG, Fredberg JJ. Interrupter resistance elucidated by alveolar pressure measurement in open-chest normal dogs. J Appl Physiol 1988;65:408-14.
32. Saldiva PH, Zin WA, Santos RL, Eidelman DH, Milic-Emili J. Alveolar pressure measurement in open-chest rats. J Appl Physiol 1992;72:302-6.
33. Freudenberg MA, Tchaptchet S, Keck S, Fejer G, Huber M, Schutze N, et al. Lipopolysaccharide sensing an important factor in the innate immune response to Gram-negative bacterial infections: benefits and hazards of LPS hypersensitivity. Immunobiology 2008;213:193-203.
34. Chen H, Bai C, Wang X. The value of the lipopolysaccharide-induced acute lung injury model in respiratory medicine. Expert Rev Respir Med 2010;4:773-83.
35. Ware LB. Pathophysiology of acute lung injury and the acute respiratory distress syndrome. Semin Respir Crit Care Med 2006;27:337-49. (Pubitemid 44272603)
36. Jacobson JR, Barnard JW, Grigoryev DN, Ma SF, Tuder RM, Garcia JG. Simvastatin attenuates vascular leak and inflammation in murine inflammatory lung injury. Am J Physiol Lung Cell Mol Physiol 2005;288:L1026-32. (Pubitemid 40695427)
37. Chen W, Sammani S, Mitra S, Ma SF, Garcia JG, Jacobson JR. Critical role for integrin-beta4 in the attenuation of murine acute lung injury by simvastatin. Am J Physiol Lung Cell Mol Physiol; 2012;303:L279-85.
38. Meroni PL, Raschi E, Testoni C, TincaniA, Balestrieri G,Molteni R, et al. Statins prevent endothelial cell activation induced by antiphospholipid (anti-beta2-glycoprotein I) antibodies: effect on the proadhesive and proinflammatory phenotype. Arthritis Rheum 2001;44:2870-8. (Pubitemid 34016207)
39. Zapolska-Downar D, Siennicka A, Kaczmarczyk M, Kolodziej B, Naruszewicz M. Simvastatin modulates TNFalpha-induced adhesion molecules expression in human endothelial cells. Life Sci 2004;75:1287-302. (Pubitemid 38845028)
40. Rodriguez AL, Wojcik BM, Wrobleski SK, Myers Jr DD, Wakefield TW, Diaz JA. Statins, inflammation and deep vein thrombosis: a systematic review. J Thromb Thrombolysis; 2012;33:371-82.
41. Sampson UK, Fazio S, Linton MF. Residual cardiovascular risk despite optimal LDL cholesterol reduction with statins: the evidence, etiology, and therapeutic challenges. Curr Atheroscler Rep; 2012;14:1-10.
42. Bhargava M, Wendt CH. Biomarkers in acute lung injury. Transl Res; 2012;159: 205-17.
43. Murrow JR, Sher S, Ali S, Uphoff I, Patel R, Porkert M, et al. The differential effect of statins on oxidative stress and endothelial function: atorvastatin versus pravastatin. J Clin Lipidol; 2012;6:42-9.
44. Pruefer D, Scalia R, Lefer AM. Simvastatin inhibits leukocyte-endothelial cell interactions and protects against inflammatory processes in normocholesterolemic rats. Arterioscler Thromb Vasc Biol 1999;19:2894-900. (Pubitemid 30029815)
45. Kowalski J, Barylski M, Banach M, Grycewicz J, Irzmanski R, Pawlicki L. Neutrophil superoxide anion generation during atorvastatin and fluvastatin therapy used in coronary heart disease primary prevention. J Cardiovasc Pharmacol 2006;48: 143-7. (Pubitemid 44691215)
46. Gaugler MH, Vereycken-Holler V, Squiban C, Vandamme M, Vozenin-Brotons MC, BenderitterM. Pravastatin limits endothelial activation after irradiation and decreases the resulting inflammatory and thrombotic responses. Radiat Res 2005;163:479-87. (Pubitemid 41490643)
47. Quist-Paulsen P. Statins and inflammation: an update. Curr Opin Cardiol; 2010;25:399-405.
48. Iwata A, Shirai R, Ishii H, Kushima H, Otani S, Hashinaga K, et al. Inhibitory effect of statins on inflammatory cytokine production from human bronchial epithelial cells. Clin Exp Immunol 2012;168:234-40.
49. Wu Y, Lv J, Feng D, Jiang F, Fan X, Zhang Z, et al. Restoration of alveolar type II cell function contributes to simvastatin-induced attenuation of lung ischemiareperfusion injury. Int J Mol Med 2012;30:1294-306.
50. Wu BQ, Luo JM,Wang YH, Shi YF, Liu H, Ba JH, et al. Inhibitory effects of simvastatin on staphylococcus aureus lipoteichoic acid-induced inflammation in human alveolar macrophages. Clin Exp Med 2013, http://dx.doi.org/10.1007/s10238- 013-0231-z.
51. Suda K, Eom J, Jaw JE, Mui T, Bai N, Or C, et al. Endotoxin-induced cardiovascular dysfunction in mice: effect of simvastatin. J Appl Physiol; 2011;111:1118-24.
52. YaoHW, Mao LG, Zhu JP. Protective effects of pravastatin in murine lipopolysaccharideinduced acute lung injury. Clin Exp Pharmacol Physiol 2006;33:793-7.
53. Grommes J, Vijayan S, Drechsler M, Hartwig H, Morgelin M, Dembinski R, et al. Simvastatin reduces endotoxin-induced acute lung injury by decreasing neutrophil recruitment and radical formation. PLoS One; 2012;7:e38917.
54. Altintas ND, Atilla P, Iskit AB, Topeli A. Long-term simvastatin attenuates lung injury and oxidative stress in murine acute lung injury models induced by oleic Acid and endotoxin. Respir Care; 2011;56:1156-63.
55. Passi S, Stancato A, Aleo E, Dmitrieva A, Littarru GP. Statins lower plasma and lymphocyte ubiquinol/ubiquinone without affecting other antioxidants and PUFA. Biofactors 2003;18:113-24. (Pubitemid 38030705)
56. Uchida T. Acute lung injury and alveolar epithelial function. J Anesth; 2011;25:152-4.
57. Craig TR, Duffy MJ, Shyamsundar M, McDowell C, O'Kane CM, Elborn JS, et al. A randomized clinical trial of hydroxymethylglutaryl- coenzymea reductase inhibition for acute lung injury (The HARP Study). Am J Respir Crit Care Med; 2011;183:620-6.